CapitalBio Eye Segment Analysis Device

The Eye Segment Analysis Device, independently developed by CapitalBio Technology, is based on the practice of traditional Chinese medicine eye diagnosis and the theory of microcirculation of the bulbar conjunctiva of Western medicine. Combined with clinical big data using artificial intelligence (AI) and shadowless imaging optical technology, high-definition acquisition, feature extraction, and comprehensive analysis of eye images can automatically determine TCM syndromes and prone diseases, and provide personalized health management solutions.